What question did this study set out to answer?

The main aim is to evaluate how treatment affects glucose metabolism in pancreatic ductal adenocarcinoma tumors.

April 8, 2026Magnetic Resonance Materials in Physics Biology and Medicine1 citationsOpen Access

Assessing the treatment of pancreatic ductal adenocarcinoma by deuterium metabolic imaging: a preclinical study

EMElton Tadeu MontraziWeizmann Institute of Science MKMaya KovalevskyWeizmann Institute of Science KSKeren SassonWeizmann Institute of Science

Key Points

The main aim is to evaluate how treatment affects glucose metabolism in pancreatic ductal adenocarcinoma tumors.
Conducted preclinical trials using deuterium metabolic imaging to assess tumor metabolism.
Analyzed metabolic kinetics of glucose in pancreatic ductal adenocarcinoma tumors before and after treatment.
Treatment significantly alters glucose metabolism in tumors.
Disruptions in metabolic correlations may indicate whether treatment is successful or not.

Abstract

The study demonstrates that CP treatment fundamentally alters the metabolic kinetics of glucose in PDAC tumors, inducing disruptions in metabolic correlations that may serve for distinguishing therapeutic success from failure.

AI से पूछें

Bookmark

View Full Paper